Pleural mesothelioma (PM), a rare malignant tumor explicitly associated with asbestos and
erionite exposures, has become a global health problem due to limited treatment options …

Available medical treatments have limited impact on the survival of patients with advanced
cancer; therefore, new therapeutic strategies able to generate more effective host's immune …

Epithelioid mesothelioma is the most prevalent subtype of diffuse malignant pleural
mesothelioma in which only staging is prognostic for survival. In this study of epithelioid …

Introduction Chronic inflammation plays a key role in the pathogenesis of malignant pleural
mesothelioma (MPM) as a result of asbestos exposure. Biomarkers of systemic inflammation …

Introduction In patients with epithelioid diffuse malignant pleural mesothelioma (DMPM),
clinical stage is the current primary prognostic factor. We sought to investigate whether …

Malignant mesothelioma (MM) is an important health problem due to ongoing asbestos
exposure. Environmental asbestos exposure leads to a high risk of MM in Turkey. The …

Background: It is important to regularly update survival estimates of patients with malignant
mesothelioma as prognosis may vary according to epidemiologic factors and diagnostic and …

Background: Malignant pleural mesothelioma (MPM) represents a fatal disease with high
aggressiveness, and limited biomarkers have yet been identified for MPM. The present study …

Background Soluble mesothelin is beneficial to detect the progression and the treatment
response of malignant pleural mesothelioma. However, the prognostic value of soluble …

Introduction Malignant pleural mesothelioma (MPM) is associated with poor prognosis and
is strongly associated with occupational asbestos exposure. Given the importance of …